Zhifei Lin
No.12, Middle Urumqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway.
Journal: Acta biochimica et biophysica Sinica
Published: July 12, 2023
Correction: AADAC protects colorectal cancer liver colonization from ferroptosis through SLC7A11‑dependent inhibition of lipid peroxidation.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 25, 2022
AADAC protects colorectal cancer liver colonization from ferroptosis through SLC7A11-dependent inhibition of lipid peroxidation.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 17, 2022
IL-6 Promotes Hepatocellular Carcinoma Invasion by Releasing Exosomal miR-133a-3p.
Journal: Gastroenterology research and practice
Published: November 09, 2021
GOLM1 exacerbates CD8+ T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages.
Journal: Signal transduction and targeted therapy
Published: July 26, 2021
STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib.
Journal: Journal of hematology & oncology
Published: October 04, 2020
Prognostic impact of SET domain-containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection.
Journal: Oncology letters
Published: December 13, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026